NBP615

· SK Bioscience Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NBP615, covering 2021-10-01 to 2021-10-01. Get the full timeline:

Most recent: Clinical Trial Update: Immunogenicity and Safety Study of NBP615 in Healthy Female [Phase 1, Phase 2]